BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

  June 12, 2025

   · 

  17 min read
• Press Releases

  Relief Therapeutics Announces Results of Annual General Meeting

  June 12, 2025

   · 

  3 min read
• Press Releases

  Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025

  June 12, 2025

   · 

  1 min read
• Press Releases

  Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD™ Agents and BCL6 Ligand-Directed Degrader at EHA 2025

  June 12, 2025

   · 

  10 min read
• Press Releases

  Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate

  June 12, 2025

   · 

  6 min read
• Press Releases

  ANI Pharmaceuticals Announces Presentation of New Preclinical Data

  June 12, 2025

   · 

  10 min read
• Press Releases

  Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

  June 12, 2025

   · 

  9 min read
• Press Releases

  BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

  June 12, 2025

   · 

  6 min read
• Press Releases

  Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

  June 12, 2025

   · 

  9 min read
• Press Releases

  Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders

  June 12, 2025

   · 

  6 min read